2025 Annual Meeting​

​Executive Briefing Document

Agenda
Opening Remarks (watch session)

• David Reese, MD — Board Chair, CEO Roundtable on Cancer; Executive Vice President and Chief Technology Officer, Amgen
• Sean Khozin, MD, MPH — CEO, CEO Roundtable on Cancer & Project Data Sphere

Fireside Chat | FDA’s Oncology Agenda in an Era of Complexity (This session was not recorded)

• Moderator: Peter Pisters, MD — ​President, The University of Texas MD Anderson Cancer Center
• Special Guest: Marty Makary, MD, MPH — Commissioner, Food & Drug Administration ​

Leading Transformation at Scale (watch session)

• Moderator: Sunil Verma, MD — Senior Vice President, Global Head of Oncology, AstraZeneca
• Panelists:
  • Josh Bilenker, MD — CEO, Treeline Biosciences
  • Kim Rathmell — CEO, Ohio State University Comprehensive Cancer Center - James Cancer Hospital
  • Christopher Viehbacher — President & CEO, Biogen

​Agentic AI in Clinical Trials | Automating the Enterprise, Empowering the System (watch session)

• Moderator: Michelle Longmire, MD — CEO, Medable
• Panelists:
  • Matthew Ko — CEO, DeepScribe
  • James Kugler — Managing Director, EMD Digital
  • Kiran Patel — Vice President, Global Head, Solid Tumor Clinical Development & Diagnostics, Johnson & Johnson

Alignment Policy, Infrastructure, and Capital for a 21st-Century Cancer Innovation (watch session)

• Moderator: Paul Howard, PhD — Executive Director, Public Policy and Corporate Affairs, Amicus Therapeutics
• Panelists:
  • Kevin Bugin — Associate Vice President, Head of Global Regulatory Policy and Intelligence, Amgen
  • Andrew Emmett — Vice President, Global Regulatory Policy & Intelligence, Pfizer
  • Robin Prasad, MD, MS, MBA — Managing Partner, Bold Brain Capital
  • Kristin Schneeman — Senior Director, FasterCures, Milken Institute of Health

Setting New Standards for AI Powered Tumor Assessment (watch session)

• Moderator: Sean Khozin, MD, MPH — CEO, CEO Roundtable on Cancer & Project Data Sphere
• Introduction: Gail Stephens — Vice President, Health Care and Life Sciences, SAS Institute
  • Presenter: Ella Pavlechko, PhD — Data Scientist, SAS Institute (view poster)

Innovators Spotlight (This session was not recorded)

• Moderator: Jon McDunn, PhD — President, Project Data Sphere
• Presenters:
  • Rafael Rosengarten — CEO, Genialis, Inc. (view poster)
  • Tony Blau, MD — CEO, All4Cure (view poster)
  • Aaron Smith — Head of AI, Unlearn.ai (view poster)
  • Julie Gerardi — Chief Commercial Officer, Bioptimus (view poster)
  • Jon McDunn — President, Project Data Sphere (view poster)

Endpoints and Evidence | Redefining Measures of Progress (watch session)

• Moderator: Gideon Blumenthal, MD — Vice President, Clinical Development, Merck
• Panelists:
  • Stu Bailey — Senior Vice President, Head of Clinical Measurement Sciences, Healthcare | R&D, EMD Serono
  • Marjorie Green, MD — Senior Vice President, Head of Oncology Clinical Development, Merck & Co.
  • Jean-Charles Soria, MD, PhD — Senior Vice President, R&D Oncology, Therapeutic Area Head, Amgen
  • David Spetzler, MS, PhD, MBA — President, Caris Life Sciences

 
Breakthrough Therapies | Engineering the Next Generation of Cancer Immunotherapy (watch session)

• Moderator: Zhen Su, MD, MBA — CEO, Marengo Therapeutics
• Panelists:
  • Christian Hinrichs, MD — Chief, Section of Cancer Immunotherapy, Rutgers Cancer Institute
  • Sushil Patel, PhD — CEO, Replimune
  • Alicia Zhou, PhD — CEO, Cancer Research Institute

 
Closing Remarks | Forward Focused (watch session)

• Sean Khozin, MD, MPH — CEO, CEO Roundtable on Cancer & Project Data Sphere 
• David Reese, MD — Board Chair, CEO Roundtable on Cancer; Executive Vice President and Chief Technology Officer, Amgen